Home | Welcome to Contract Pharma   
Last Updated Friday, August 1 2014
Print

STADA Licenses Transdermal Patch from 3M DDS



Published November 20, 2013
STADA Arzneimittel AG has licensed 3M Drug Delivery Systems’ transdermal patch technology for the transdermal delivery of the opioid pain medication fentanyl. Terms of the agreement were not disclosed. 
 
The 3M Patent (EP 2158905) was granted on March 20, 2013 and enables the transdermal drug delivery of a therapeutically effective amount of fentanyl across the skin of a patient. The matrix device incorporates fentanyl into an adhesive matrix made of a copolymer containing alkyl acrylate and other monomers.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On